BE606063A - Dérivés thiadiaziniques et leur préparation. - Google Patents

Dérivés thiadiaziniques et leur préparation.

Info

Publication number
BE606063A
BE606063A BE606063A BE606063A BE606063A BE 606063 A BE606063 A BE 606063A BE 606063 A BE606063 A BE 606063A BE 606063 A BE606063 A BE 606063A BE 606063 A BE606063 A BE 606063A
Authority
BE
Belgium
Prior art keywords
preparation
thiadiazine derivatives
thiadiazine
derivatives
Prior art date
Application number
BE606063A
Other languages
English (en)
French (fr)
Inventor
James Michael Mcmanus
William Merrill Mclamore
Original Assignee
Pfizer & Co C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer & Co C filed Critical Pfizer & Co C
Publication of BE606063A publication Critical patent/BE606063A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15Six-membered rings
    • C07D285/16Thiadiazines; Hydrogenated thiadiazines
    • C07D285/181,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • C07D285/201,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
    • C07D285/221,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D285/241,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
    • C07D285/261,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals
    • C07D285/301,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals with hydrocarbon radicals, substituted by hetero atoms, attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04DNON-POSITIVE-DISPLACEMENT PUMPS
    • F04D29/00Details, component parts, or accessories
    • F04D29/08Sealings
    • F04D29/10Shaft sealings
    • F04D29/12Shaft sealings using sealing-rings
    • F04D29/126Shaft sealings using sealing-rings especially adapted for liquid pumps
    • F04D29/128Shaft sealings using sealing-rings especially adapted for liquid pumps with special means for adducting cooling or sealing fluid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mechanical Engineering (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Structures Of Non-Positive Displacement Pumps (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
BE606063A 1960-09-27 1961-07-12 Dérivés thiadiaziniques et leur préparation. BE606063A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58632A US3102882A (en) 1960-09-27 1960-09-27 Derivatives of 3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide
GB991/61A GB902658A (en) 1960-09-27 1961-01-10 6-substituted (or unsubstituted) 2-alkyl-3-allylthiomethyl-7-sulphamyl-3,4-dihydrobenzothiadiazine dioxides and process for preparation

Publications (1)

Publication Number Publication Date
BE606063A true BE606063A (fr) 1962-01-12

Family

ID=26236340

Family Applications (1)

Application Number Title Priority Date Filing Date
BE606063A BE606063A (fr) 1960-09-27 1961-07-12 Dérivés thiadiaziniques et leur préparation.

Country Status (6)

Country Link
US (1) US3102882A (US07368562-20080506-C00017.png)
BE (1) BE606063A (US07368562-20080506-C00017.png)
DE (2) DE1445121A1 (US07368562-20080506-C00017.png)
ES (1) ES270748A1 (US07368562-20080506-C00017.png)
FR (1) FR1426M (US07368562-20080506-C00017.png)
GB (2) GB902658A (US07368562-20080506-C00017.png)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3265573A (en) * 1962-07-27 1966-08-09 Squibb & Sons Inc Benzothiadiazinesulfonamide-1, 1-dioxide composition
US3251837A (en) * 1962-09-14 1966-05-17 Pfizer & Co C Derivatives of 1, 2, 4-benzothiadiazine-1, 1-dioxides
US4338435A (en) * 1981-06-01 1982-07-06 E. R. Squibb & Sons, Inc. Benzothiadiazines having diuretic activity
AU2003250483A1 (en) 2002-08-19 2004-03-11 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
DE602004016123D1 (de) 2003-03-07 2008-10-09 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
ATE418551T1 (de) 2003-03-07 2009-01-15 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのcetp阻害剤としてのn−((3−ベンジル)−2,2−(ビス−フェニル)−プロパン−1−アミン誘導体
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EA020466B1 (ru) 2007-06-04 2014-11-28 Синерджи Фармасьютикалз Инк. Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
CN113388007A (zh) 2013-06-05 2021-09-14 博士医疗爱尔兰有限公司 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
JOP20210193A1 (ar) 2019-01-18 2023-01-30 Astrazeneca Ab مثبطات pcsk9 وطرق استخدامها

Also Published As

Publication number Publication date
US3102882A (en) 1963-09-03
GB905137A (en) 1962-09-05
DE1302648B (US07368562-20080506-C00017.png)
FR1426M (fr) 1962-08-06
GB902658A (en) 1962-08-09
ES270748A1 (es) 1961-12-16
DE1445121A1 (de) 1968-11-28

Similar Documents

Publication Publication Date Title
BE606063A (fr) Dérivés thiadiaziniques et leur préparation.
FR1271180A (fr) Cyclododécylguanidine et ses dérivés et leur préparation
BE602888A (fr) Nouveaux dérivés de 8-benzylxanthines et leur préparation.
BE611000A (fr) Dérivés de benzazocines et leur préparation
BE607171A (fr) Dérivés d'alanine et leur préparation
FR1288907A (fr) Dérivés de cystéine et leur préparation
OA00151A (fr) Nouveaux dérivés pyrazolidiniques et leur préparation.
OA01362A (fr) Nouvelles phényl-alkylamines et leur préparation.
FR1336070A (fr) Dérivés de la phénoxazine et leur préparation
BE604996A (fr) Dérivés de la 1,2,3,4-tétrahydroquinazolinone et leur préparation
BE608433A (fr) Nouvelles morpholinones et leur préparation.
FR1302943A (fr) Benzylguanidines et leur préparation
FR1445453A (fr) Phénylcyclopropyl-amides et leur préparation
BE619835A (fr) Dérivés de la thiamine et leur préparation
BE604111A (fr) Dérivés éthyléniques et leur préparation.
BE602887A (fr) Nouveaux dérivés de 8-benzylxanthines et leur préparation.
BE600673A (fr) Dérivés de phénylalanine et leur préparation
BE613226A (fr) Dérivés de la 1.2.4-benzothiadiazine et leur préparation
BE603114A (fr) Nouveaux dérivés des dialkylxanthines et leur préparation
FR1388605A (fr) Dérivés de sérine et leur préparation
FR1294115A (fr) Dérivés du thiaxanthène et leur préparation
BE602326A (fr) Dérivés du thiophénicol et leur préparation
FR1300734A (fr) Phényl-thiopurines et leur préparation
BE607685A (fr) Préparation de 1,2-diphényl-4-carbamoyl-3,5 pyrazolidinedione.
BE613750A (fr) Dérivés de dibenzocycloheptadiènes et leur préparation